Cell Proliferation Kit Market Size & Share, by Assay Type (DNA Synthesis Cell Proliferation Assay, Metabolic Activity Cell Proliferation Assay, Antigen Associated Cell Proliferation Assay); Method (Colorimetry, Fluorescence); End-user (Pharma & Biotech Companies, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3860
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cell Proliferation Kit Landscape

top-features-companies
    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • General Electric Company
    • PerkinElmer Inc.
    • F. Hoffmann-La Roche AG
    • Biotium, Inc.
    • Mindray Medical International Limited
    • Biological Industries

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fisher Scientific, Inc. deals with EDF Renewables to provide with about 545,000 MWh of renewable power per year from the Millers Branch Solar project in Texas. Further, by 2026, all of the company's current U.S. facilities will be powered entirely by renewable energy with a goal to help the customers make the world healthier, cleaner, and safer.

  •  Biotium, Inc.  a provider of a provider of modern life science reagents, and Cell Data Sciences, a maker of RNAstorm and DNAstorm™ kits for RNA/DNA extraction, teamed up to provide a combined pricing for the DNAstormTM and RNAstormTM FFPE extraction kits in comparison to buying each kit separately.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3860
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing rate of patients diagnosed with cancer & tumors, and the rising conscious towards healthcare are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 12% over the forecast period, i.e., 2023-2035.

Lack of highly qualified medical personnel in poor economic areas, and dearth of knowledge are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, General Electric Company, PerkinElmer Inc., F. Hoffmann-La Roche AG, Biotium, Inc, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by assay type, method, end user, and by region.

The colorimetry segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying